Keep up to date with every new upload!

Join free & follow Journal of Oncology Practice P
Share
  • 6 years ago
Barriers to Prescribing Crizotinib Following FDA Approval

Barriers to Prescribing Crizotinib Following FDA Approval

by Robert S. Miller, MD. Dr. Nathan Pennell discusses some of the interesting obstacles he encountered when trying to prescribe crizotinib for 3 patients with ALK positive non-small cell lung cancer in the first few weeks following FDA approval in 2011.

Comments